Lupin has completed the acquisition of 42.61% of the equity share capital of Sunsure Solarpark Seventeen (Sunsure Solarpark) and successfully completed the Transaction. The company has completed the acquisition on January 9, 2025.
Earlier, the company had signed Share Subscription & Shareholders agreement with Sunsure Solarpark and Sunsure Energy (Sunsure) to make equity investment upto 42.61% of equity share capital of Sunsure Solarpark to be acquired at a total consideration not exceeding Rs 10.55 crore, to be completed in two tranches, in the capacity as a Captive User.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
